Segment Information

3 Months Ended

Mar. 30, 2012

Segment Information [Abstract]

Segment Information

NOTE 12. SEGMENT INFORMATION

The Company operates and reports its results in five separate business segments consisting of the Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies segments. The Company's equity in earnings of the Apex joint venture is shown separately in the Company's segment disclosures. There has been no material change in total assets or liabilities by segment since December 31, 2011, except for the sale of the ASI and KEO businesses from the Industrial Technologies segment in January and February 2012, respectively.

Segment results are shown below ($ in millions):

	Sales				Operating Profit
	Three Months Ended				Three Months Ended
	March 30, 2012		April 1, 2011		March 30, 2012			April 1, 2011
Test & Measurement	$	846.4	$	830.5	$	191.6		$	172.2
Environmental		694.6		668.0		129.1			128.9
Life Sciences & Diagnostics		1,545.9		626.6		205.9			90.4
Dental		464.7		463.5		58.9			49.5
Industrial Technologies		764.6		703.6		157.8			155.8
Equity method earnings of Apex joint venture		—		—		14.3			14.5
Other		—		—		(22.7	)		(26.5	)
	$	4,316.2	$	3,292.2	$	734.9		$	584.8